Frequently Asked Questions
The COVID-19 epidemic has expedited the development of innovative biologics and vaccination technologies. These factors will likely expand the prospects for making and preserving biologics, increasing demand for the biopreservation market.
In 2022, North America held the largest share of the global biopreservation market.
Growing healthcare spending, the existence of government healthcare initiatives that offer funding, grants, and research contracts, technological advancements in biopreservation processes, and rising R&D expenditures by businesses and research communities to improve their capabilities and provide effective products and services are key factors that are propelling the growth of the global biopreservation market.
The equipment segment had a major share in the global market.
The bio-banking segment had a major share in the global market in 2022.